Literature DB >> 23186808

Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors.

Lian Engelen1, Isabel Ferreira, Coen D Stehouwer, Pierre Boutouyrie, Stéphane Laurent.   

Abstract

AIMS: Common carotid artery intima-media thickness (CCIMT) is widely used as a surrogate marker of atherosclerosis, given its predictive association with cardiovascular disease (CVD). The interpretation of CCIMT values has been hampered by the absence of reference values, however. We therefore aimed to establish reference intervals of CCIMT, obtained using the probably most accurate method at present (i.e. echotracking), to help interpretation of these measures. METHODS AND
RESULTS: We combined CCIMT data obtained by echotracking on 24 871 individuals (53% men; age range 15-101 years) from 24 research centres worldwide. Individuals without CVD, cardiovascular risk factors (CV-RFs), and BP-, lipid-, and/or glucose-lowering medication constituted a healthy sub-population (n = 4234) used to establish sex-specific equations for percentiles of CCIMT across age. With these equations, we generated CCIMT Z-scores in different reference sub-populations, thereby allowing for a standardized comparison between observed and predicted ('normal') values from individuals of the same age and sex. In the sub-population without CVD and treatment (n = 14 609), and in men and women, respectively, CCIMT Z-scores were independently associated with systolic blood pressure [standardized βs 0.19 (95% CI: 0.16-0.22) and 0.18 (0.15-0.21)], smoking [0.25 (0.19-0.31) and 0.11 (0.04-0.18)], diabetes [0.19 (0.05-0.33) and 0.19 (0.02-0.36)], total-to-HDL cholesterol ratio [0.07 (0.04-0.10) and 0.05 (0.02-0.09)], and body mass index [0.14 (0.12-0.17) and 0.07 (0.04-0.10)].
CONCLUSION: We estimated age- and sex-specific percentiles of CCIMT in a healthy population and assessed the association of CV-RFs with CCIMT Z-scores, which enables comparison of IMT values for (patient) groups with different cardiovascular risk profiles, helping interpretation of such measures obtained both in research and clinical settings.

Entities:  

Keywords:  Ageing; Atherosclerois; Carotid intima-media thickness; Echotracking; Reference intervals; Risk factors

Mesh:

Year:  2012        PMID: 23186808     DOI: 10.1093/eurheartj/ehs380

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  66 in total

Review 1.  Structural and Functional Abnormalities of Carotid Artery and Their Relation with EVA Phenomenon.

Authors:  Alessandro Maloberti; Paolo Meani; Marisa Varrenti; Luca Giupponi; Miriam Stucchi; Paola Vallerio; Cristina Giannattasio
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-05-19

Review 2.  Arterial structure and function in vascular ageing: are you as old as your arteries?

Authors:  Dick H J Thijssen; Sophie E Carter; Daniel J Green
Journal:  J Physiol       Date:  2015-07-27       Impact factor: 5.182

3.  Comparative Analysis of Arterial Parameters Variations Associated with Inter-Individual Variations in Peripheral and Aortic Blood Pressure: Cross-Sectional Study in Healthy Subjects Aged 2-84 years.

Authors:  Yanina Zócalo; Santiago Curcio; Victoria García-Espinosa; Pedro Chiesa; Gustavo Giachetto; Daniel Bia
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-09-25

4.  Genetic influence on femoral plaque and its relationship with carotid plaque: an international twin study.

Authors:  Pierleone Lucatelli; Corrado Fagnani; Adam Domonkos Tarnoki; David Laszlo Tarnoki; Beatrice Sacconi; Bence Fejer; Maria Antonietta Stazi; Miriam Salemi; Carlo Cirelli; Alessandro d'Adamo; Fabrizio Fanelli; Carlo Catalano; Pal Maurovich-Horvat; Adam L Jermendy; Gyorgy Jermendy; Bela Merkely; Andrea A Molnar; Giacomo Pucci; Giuseppe Schillaci; Filippo Farina; Giorgio Meneghetti; Claudio Baracchini; Emanuela Medda
Journal:  Int J Cardiovasc Imaging       Date:  2017-10-11       Impact factor: 2.357

Review 5.  Relation between age and carotid artery intima-medial thickness: a systematic review.

Authors:  Inge C L van den Munckhof; Helen Jones; Maria T E Hopman; Jacqueline de Graaf; Jean Nyakayiru; Bart van Dijk; Thijs M H Eijsvogels; Dick H J Thijssen
Journal:  Clin Cardiol       Date:  2018-05-12       Impact factor: 2.882

6.  Carotid and aortic stiffness in essential hypertension and their relation with target organ damage: the CATOD study.

Authors:  Rosa Maria Bruno; Giulia Cartoni; Francesco Stea; Sabina Armenia; Elisabetta Bianchini; Simona Buralli; Chiara Giannarelli; Stefano Taddei; Lorenzo Ghiadoni
Journal:  J Hypertens       Date:  2017-02       Impact factor: 4.844

7.  Increased maximum common carotid intima-media thickness is associated with smoking and hypertension in Tochigi Prefecture residents.

Authors:  Akio Iwasaki; Hidehiro Takekawa; Ryuta Okabe; Keisuke Suzuki; Madoka Okamura; Takahito Nishihira; Ayano Suzuki; Yuka Tsukahara; Koichi Hirata
Journal:  J Med Ultrason (2001)       Date:  2017-02-15       Impact factor: 1.314

8.  Quantification of the Interrelationship between Brachial-Ankle and Carotid-Femoral Pulse Wave Velocity in a Workplace Population.

Authors:  Yi-Bang Cheng; Yan Li; Chang-Sheng Sheng; Qi-Fang Huang; Ji-Guang Wang
Journal:  Pulse (Basel)       Date:  2016-03-15

9.  Arsenic and subclinical vascular damage in a sample of Italian young adults: a cross-sectional analysis.

Authors:  Francesco Stea; Francesco Faita; Andrea Borghini; Francesca Faita; Fabrizio Bianchi; Elisa Bustaffa; Fabrizio Minichilli; Maria Grazia Andreassi; Rosa Sicari
Journal:  Environ Sci Pollut Res Int       Date:  2016-07-23       Impact factor: 4.223

10.  Effect of Angiotensin II Type I Receptor Blockade with Valsartan on Carotid Artery Atherosclerosis: A Double Blind Randomized Clinical Trial Comparing Valsartan and Placebo (EFFERVESCENT).

Authors:  Ronnie Ramadan; Saurabh S Dhawan; José Nilo G Binongo; Ayman Alkhoder; Dean P Jones; John N Oshinski; Arshed A Quyyumi
Journal:  Am Heart J       Date:  2016-01-18       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.